Polo, R; García-Albéniz, X; Terán, C; Morales, M; Rial-Crestelo, D; Garcinuño, MA; del Toro, MG; Hita, C; Gómez-Sirvent, JL; Buzón, L; de Santiago, AD; Arellano, JP; Sanz, J; Bachiller, P; Alfaro, EM; Díaz-Brito, V; Masiá, M; Hernández-Torres, A; Guerra, JM; Santos, J; Arazo, P; Muñoz, L; Arribas, JR; de Salazar, PM; Moreno, S; Hernán, MA; Del Amo, J – 2023 – 10.1016/j.cmi.2022.07.006
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers. – CLINICAL MICROBIOLOGY AND INFECTION
por prodriguez | Ene 1, 2023 | Publicaciones - DE-02 | 0 Comentarios